Correlation Between Dominari Holdings and Humacyte

Can any of the company-specific risk be diversified away by investing in both Dominari Holdings and Humacyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dominari Holdings and Humacyte into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dominari Holdings and Humacyte, you can compare the effects of market volatilities on Dominari Holdings and Humacyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dominari Holdings with a short position of Humacyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dominari Holdings and Humacyte.

Diversification Opportunities for Dominari Holdings and Humacyte

-0.66

Correlation Coefficient

Dominari Holdings  Humacyte

Excellent diversification

The 3 months correlation between Dominari and Humacyte is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Dominari Holdings and Humacyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Humacyte and Dominari Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dominari Holdings are associated (or correlated) with Humacyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Humacyte has no effect on the direction of Dominari Holdings i.e., Dominari Holdings and Humacyte go up and down completely randomly.

Pair Corralation between Dominari Holdings and Humacyte

Given the investment horizon of 90 days Dominari Holdings is expected to under-perform the Humacyte. But the stock apears to be less risky and, when comparing its historical volatility, Dominari Holdings is 2.91 times less risky than Humacyte. The stock trades about -0.15 of its potential returns per unit of risk. The Humacyte is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest  186.00  in Humacyte on March 28, 2024 and sell it today you would lose (36.00) from holding Humacyte or give up 19.35% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Dominari Holdings  vs.  Humacyte

Dominari Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dominari Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's primary indicators remain fairly strong which may send shares a bit higher in July 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Humacyte

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Humacyte are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Humacyte showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Dominari Holdings and Humacyte

The main advantage of trading using opposite Dominari Holdings and Humacyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dominari Holdings position performs unexpectedly, Humacyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Humacyte will offset losses from the drop in Humacyte's long position.

The idea behind Dominari Holdings and Humacyte pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.